Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recentonset type 1 diabetes: A randomized double-blind trial

D. K. Wherrett, B. Bundy, D. J. Becker, L. A. DiMeglio, S. E. Gitelman, R. Goland, P. A. Gottlieb, C. J. Greenbaum, K. C. Herold, J. B. Marks, R. Monzavi, A. Moran, T. Orban, J. P. Palmer, P. Raskin, H. Rodriguez, D. Schatz, D. M. Wilson, J. P. Krischer, J. S. Skyler

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recentonset type 1 diabetes: A randomized double-blind trial'. Together they form a unique fingerprint.